Blb&B Advisors, LLC Angion Biomedica Corp. Call Options Transaction History

Blb&B Advisors, LLC

  • $1.76 Billion
  • Q1 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email